CRISPR Therapeutics AG
Asset & Liabilities Breakdown
Asset Breakdown FY2019
Total Assets: $1.07B
Liabilities Breakdown FY2019
Total Liabilities: $127.3M
Asset Breakdown
Total Assets: $1.07B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $943.8M | 88.5% |
| Accounts Receivable | $99.0K | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $31.3M | 2.9% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $235.0K | 0.0% |
| Other Assets | $91.3M | 8.6% |
Liabilities Breakdown
Total Liabilities: $127.3M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $5.9M | 4.7% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $121.4M | 95.3% |